ACADIA Pharmaceuticals Inc.
3611 Valley Centre Drive
ACADIA’s history is rooted in science and strong leadership in central nervous system (CNS) research. Since the beginning, we have been dedicated to improving the lives of patients suffering from CNS disorders. All programs in our pipeline emanate from discoveries made at ACADIA
Clinical trials are research studies that are designed to determine if a medicine is safe and effective for patients. The U.S. National Institutes of Health provides a website of clinical trials. To learn more about clinical trials that are underway at ACADIA, please visit clinicaltrials.gov.
Medical Education Grants:
ACADIA is committed to supporting independent medical education through grants. Our particular focus is in educational initiatives which improve disease awareness and patient care related to the neuropsychiatric complications of Parkinson’s disease. Requests outside of this area will not be considered. We support programs which aim to do the following
- Educate healthcare professionals on disease diagnosis and appropriate treatments;
- Inform patients and their caregivers about disease awareness, screening and management;
- Advance scientific education; and
- Improve the quality of care for patients.
- Accredited Educational Partners
- Medical or Professional Associations or Societies
- Community Health Centers, Hospitals or Academic Medical Centers
- Disease-related Organizations and Advocacy Groups
- Medical Education Companies
At ACADIA, we are dedicated to bringing innovative medicines to patients with central nervous system (CNS) disorders. We are committed to partnerships and collaborations to expand access to our future products and to complement our portfolio of product candidates.
As part of our strategy, we selectively pursue strategic collaborations to advance and maximize the commercial potential of our pipeline. In areas where our products can be commercialized by a specialty sales force that calls on a limited and focused group of physicians, we plan to commercialize our product candidates in the United States. In therapeutic areas that require large specialty or primary care sales forces, we may choose to conduct commercialization through, or in collaboration with, partners. We plan to commercialize our products in markets outside of the United States on our own or by establishing strategic alliances.
ACADIA’s mission is to be the leading pharmaceutical company dedicated to the advancement of innovative medicines that improve the lives of patients with central nervous system disorders.
We are driven to improve lives – we never lose sight of our patients and their families.
None of us is as smart as all of us – we believe all ideas and outcomes are improved through collaboration.
Mutual respect, integrity and trust are our foundation.
We challenge conventional thinking.
Overcoming barriers is core to our culture – we never give up.
We get things done – excellence is the result of our focus, expertise and perseverance.
We take our work seriously (but not ourselves)
ACADIA’s stimulating work environment is enhanced by our Total Rewards philosophy. In addition to competitive compensation, we offer a great mix of programs to benefit you and your family.
Health and Wellness
Two medical insurance plans including an HMO (Health Maintenance Organization—CA only) and a PPO (Preferred Provider Organization) plan
Dental PPO plan
Flexible Spending Accounts for Health and Dependent Care
In collaboration with Allergan, we have discovered small-molecule product candidates for the treatment of chronic pain. Our novel alpha adrenergic agonists are designed to provide pain relief without the side effects of current pain therapies including sedation and cardiovascular and respiratory effects.
About Chronic Pain
Chronic pain is a common form of pain that persists or progresses over a long period of time. In contrast to acute pain that usually arises suddenly in response to an identifiable injury and is transient, chronic pain persists over time and is often resistant to medical treatments. Chronic pain may be related to a number of different medical conditions, including diabetes, arthritis, migraine, fibromyalgia, irritable bowel syndrome, cancer, shingles, and previous trauma or injury. Due to the shortcomings of current therapies, we believe that there is a large unmet medical need for new chronic pain therapies with improved efficacy and side effect profiles.
Krebs Biochemicals & Industries Limited
click above to visit
this company/ organization